May 23, 2026
— Jeff Ward, Lehigh Valley News Briefs
Shares of OraSure (NASDAQ:OSUR) have been rising. They were just over the $3 mark on May 18, but rose through the week for to $3.60.
OraSure shares have been duds since the COVID-19 epidemic ended. Federal aid to the company was cut.
Other things that might be pushing up the stock include speculation on off-market products that might become commercial, or of renewed investor interest in seeking ways to make the company profitable.
Orasure may be drawing interest because of Ebola breakouts in Africa. OraSure’s product line includes a rapid test for Ebola.
Also. A few investors have said the company needs changes and perhaps it should be sold
Right now, I’m going with Ebola as the booster. There’s no specific news under the ticker .
South Bethlehem-based OraSure started as SolarCare, maker of sunscreen towelettes.
Here’s a link to OraSure’s website:
Lehigh Valley News Briefs 